Teva Pharmaceutical Industries revenue and financials
$39.66Change from previous close: +0.33%Absolute change: +$0.13
In the fiscal year ended December 2025, Teva Pharmaceutical Industries reported revenue of $17.26B (+4.32% year over year). Net income was $1.41B, a net margin of 8.2%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +4.32%
- 2025 vs 2024
- Net margin
- 8.2%
- 2024: -9.9%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 17,258 | 16,544 | 15,846 | 14,925 | 15,878 | 16,659 | 16,887 | 18,271 | 21,853 | 21,903 |
| Cost of revenue | 8,320 | 8,481 | 8,200 | 7,952 | 8,284 | 8,933 | 9,351 | 9,975 | 11,237 | 10,250 |
| Gross profit | 8,938 | 8,064 | 7,645 | 6,973 | 7,594 | 7,726 | 7,537 | 8,296 | 10,615 | 11,653 |
| Selling, general and administrative | 3,973 | 3,702 | 3,498 | 3,445 | — | — | — | — | — | — |
| Research and development | 1,013 | 998 | 953 | 98.0 | — | — | — | 114 | 175 | 422 |
| Operating income | 2,157 | -303 | 433 | -2,197 | 1,716 | -3,572 | -443 | -1,637 | -17,484 | 2,154 |
| EBIT | 2,139 | -282 | 405 | -2,233 | — | — | — | — | — | — |
| EBITDA | 3,141 | 777 | 1,558 | -925 | — | — | — | — | — | — |
| Interest expense | 916 | 1,002 | 1,029 | 930 | 891 | 901 | 822 | 920 | 875 | 546 |
| Pre-tax income | 1,223 | -1,284 | -624 | -3,163 | — | — | — | — | — | — |
| Income tax | -180 | 676 | -7.0 | -643 | 211 | -168 | -278 | -195 | -1,933 | 521 |
| Net income | 1,410 | -1,639 | -559 | -2,446 | 417 | -3,990 | -999 | -2,150 | -16,265 | 329 |
| Net income to common shareholders | 1,410 | -1,639 | -559 | -2,446 | — | — | — | — | — | — |
| Basic EPS | 1.23 | -1.45 | -0.50 | -2.20 | 0.38 | -3.64 | -0.91 | -2.35 | -16.26 | 0.07 |
| Diluted EPS | 1.21 | -1.45 | -0.50 | -2.20 | 0.38 | -3.64 | -0.91 | -2.35 | -16.26 | 0.07 |
| Average shares (basic) | 1,145 | 1,131 | 1,119 | 1,110 | — | — | — | — | — | — |
| Average shares (diluted) | 1,163 | 1,131 | 1,119 | 1,110 | 1,107 | 1,095 | 1,091 | 1,021 | 1,016 | 0.0 |